Pyxis Oncology Q3 EPS $(0.24) Beats $(0.29) Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.29) by 17.24 percent. This is a 31.43 percent increase over losses of $(0.35) per share from
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.29) by 17.24 percent. This is a 31.43 percent increase over losses of $(0.35) per share from the same period last year.
